DIN 02354586 — RENVELA 800 MG
RENVELA is a tablet of Sevelamer marketed by SANOFI-AVENTIS CANADA INC. The full Sevelamer monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02354586
- Brand name
- RENVELA
- Active ingredient
- Sevelamer
- Strength
- 800 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Non-absorbed polymer phosphate binder
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sevelamer products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02461501 | ACCEL-SEVELAMER | 800 MG | TABLET | ACCEL PHARMA INC | MARKETED |
| 02244310 | RENAGEL | 800 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |